Executive Director, Investor Relations and Corporate Communications

Role: Executive Director, Investor Relations at a clinical-stage oncology biopharma focused on targeted cancer therapies, including antibody-drug conjugates and radioligand therapies. Primary objectives involve managing external communications, engaging with investors and analysts, and supporting corporate visibility. Responsibilities include executing IR programs, developing and delivering investor materials, coordinating capital markets activities, and translating complex scientific and clinical data into clear narratives. The role also requires leading corporate communications, managing external agencies, ensuring regulatory compliance, and aligning messaging across functions like Clinical, Regulatory, Legal, and Business Development. Qualifications: minimum 10 years in IR, corporate communications, or relevant biotech/life sciences roles, with public company experience and a strong scientific literacy. Candidates should demonstrate proficiency in high-stakes communications, financial acumen, and stakeholder engagement, along with experience managing external agencies. Knowledge of biotech sector dynamics, public markets, and experience communicating clinical and development strategies are essential. The position reports directly to the CFO, with a focus on strategic messaging, market perception, and investor engagement. Work setup and travel specifics are not detailed, but the role involves high-level external engagement and cross-functional coordination.